Nanotechnology has revolutionized cancer diagnosis and therapy through targeted drug
delivery. Advances in protein engineering and materials science have led to the
development of nanocarriers (NCs), which have helped overcome the challenges faced
during conventional cancer treatment. These nanocarriers serve as an efficient
transport module for drugs. Nano-drug delivery has emerged as a promising technology
that results in early detection and better treatment of various cancers. The
approved nanoparticles currently used in cancer treatment strategies include
liposomes, dendrimers, polyplexes, solid lipid nano-carriers, etc. These
nanocarriers shall provide a quick, safe, and cost-effective method in cancer
therapy and management.
This book contains thirteen chapters focusing on the treatment of various cancers,
i.e., lung, breast, cervical, ovarian, colon, prostate, head and neck, etc., through
nanocarrier drugs. The chapters include reviews on a wide variety of advanced data
from existing and ongoing clinical research and major regulatory considerations.
This reference book will greatly benefit undergraduate and postgraduate students,
oncologists, pharmacists, and researchers involved in nanomedicine and nano-drug